
Advancing horticultural research and innovation to support a healthy future.
Technology license for Stevia-related patents
between
Vineland Research and Innovations Centre
(as Licensor)
and
Stevia First Corporation
(as Licensee)
Table of contents
introduction | 1 |
| | |
ARTICLE 1 |
definitions | 2 |
| | |
ARTICLE 2 |
grant & reservations | 4 |
2.1 | Grant | 4 |
2.2 | Assignment of Materials | 4 |
2.3 | Carve Out | 4 |
2.4 | Sub-Licensing Conditions | 5 |
2.5 | No Sub-Licensee Encumbrances | 5 |
2.6 | Termination | 5 |
2.7 | The Company Shall Obtain Regulatory Permissions | 5 |
| | |
ARTICLE 3 |
term | 6 |
3.1 | Initial Term | 6 |
3.2 | Renewal of License | 6 |
| | |
ARTICLE 4 |
EXPLOITATION OF THE VARIETY | 6 |
4.1 | Efforts to Sell | 6 |
4.2 | Quality Control | 6 |
| | |
ARTICLE 5 |
FEES & ROYALTIES | 6 |
5.1 | Reimbursement for Fees | 6 |
5.2 | Royalty Rate | 7 |
5.3 | Minimum Royalty | 7 |
5.4 | Execution Fees | 7 |
5.5 | Sub-Licensing Consideration | 7 |
5.6 | Taxes | 7 |
5.7 | Payment to VRIC | 7 |
5.8 | Payments to VRIC after Termination | 8 |
5.9 | No Set-off | 8 |
| | |
ARTICLE 6 |
RECORDS, QUALITY CONTROL, AUDIT | 8 |
6.1 | Reports & Records | 8 |
6.2 | Quality Control Obligations | 9 |
6.3 | Quality Control Audits | 9 |
6.4 | Material Terms | 9 |
6.5 | Reports & Records Audit Rights | 9 |
6.6 | Audit Confidentiality | 9 |
6.7 | No Waiver | 10 |
6.8 | Discrepancy Percentage | 10 |
Sole License for Stevia Technology – VRIC & SteviaFirst | i |
ARTICLE 7 |
DISCLAIMERS | 10 |
7.1 | VRIC Owns | 10 |
7.2 | Company’s Rights | 10 |
7.3 | No Impeachment | 10 |
7.4 | Disclaimer of Express / Implied Warranties | 10 |
7.5 | Disclaimer of Statutorily Implied Warranties | 11 |
7.6 | No Liability to VRIC from Exercise of Rights | 11 |
7.7 | Disclosure & Due Diligence | 11 |
| | |
ARTICLE 8 |
CORPORATE REPRESENTATIONS & WARRANTIES | 12 |
8.1 | The Company Incorporated & Authorized & Bound | 12 |
8.2 | VRIC Authorized | 13 |
| | |
ARTICLE 9 |
INDEMNITY, INSURANCE, LIABILITY ALLOCATION & CAPS | 14 |
9.1 | The Company’s Indemnification | 14 |
9.2 | Indemnity Separate / Continuing | 14 |
9.3 | Insurance | 14 |
9.4 | VRIC’s Indemnity | 14 |
9.5 | VRIC’s Liability Cap | 15 |
9.6 | Excluded Heads of Damage | 15 |
9.7 | No Actions Against Employees | 15 |
9.8 | Notifications | 16 |
| | |
ARTICLE 10 |
INFRINGEMENT | 16 |
10.1 | Third Party Suit | 16 |
10.2 | Infringement Uncovered | 16 |
10.3 | Company May Sue | 16 |
10.4 | Distribution of Company’s Recovery | 16 |
10.5 | VRIC May Sue | 17 |
10.6 | Thresholds | 17 |
| | |
ARTICLE 11 |
TERMINATION | 17 |
11.1 | By VRIC for Cause | 17 |
11.2 | Automatic Termination | 19 |
11.3 | Termination Not A Penalty | 19 |
11.4 | Procedure | 19 |
11.5 | Effect on Sub-Licensees | 19 |
11.6 | The Company’s Duties on Termination | 19 |
11.7 | Surviving Obligations | 20 |
| | |
ARTICLE 12 |
INTENT & INTERPRETATION | 21 |
12.1 | Use of Alternate Dispute Resolution | 21 |
12.2 | Entire Agreement | 21 |
Sole License for Stevia Technology – VRIC & SteviaFirst | ii |
12.3 | No Third Parties | 21 |
12.4 | No Pre-Contractual Inducing Representations | 21 |
12.5 | Due Diligence Search | 22 |
12.6 | Independent Legal Advice | 22 |
12.7 | No Adverse Presumption in Case of Ambiguity | 22 |
12.8 | Severability | 22 |
12.9 | Successors and Assigns | 22 |
12.10 | Plurality & Gender | 23 |
12.11 | Not a Joint Venture | 23 |
12.12 | Compliance with Law | 23 |
12.13 | No Implied Obligations | 23 |
12.14 | Forum Conveniens & Applicable Laws | 23 |
12.15 | Attornment | 24 |
12.16 | USA Jury Trial Addendum | 24 |
12.17 | Waiver of Counterclaims | 24 |
12.18 | Due Diligence Audits | 24 |
12.19 | Recitals Accurate | 24 |
12.20 | Force majeure | 24 |
12.21 | Waiver | 26 |
12.22 | No Estoppel Due to Third Party Practices | 26 |
12.23 | Contract Always Speaks | 26 |
12.24 | Time is of the Essence | 26 |
12.25 | Headings | 27 |
12.26 | Internal References | 27 |
12.27 | Precedence Over Appendices | 27 |
12.28 | Appendices | 27 |
| | |
ARTICLE 13 |
LEGAL RIGHTS | 27 |
13.1 | Amendments | 27 |
13.2 | Assignment | 27 |
13.3 | Mode of Assignment / Approval Conditions | 27 |
13.4 | No Consent – Material Breach | 28 |
13.5 | Subcontracting | 28 |
13.6 | No Third Party Rights | 28 |
13.7 | Remedies Cumulative | 28 |
13.8 | Mutual Assistance | 28 |
| | |
ARTICLE 14 |
NOTICE | 29 |
14.1 | Addresses / Contacts | 29 |
14.2 | Deemed Delivery | 29 |
14.3 | Change of Address | 29 |
| | |
ARTICLE 15 |
PUBLIC STATEMENTS | 30 |
15.1 | Public Statements | 30 |
15.2 | Statement Exceptions | 30 |
Sole License for Stevia Technology – VRIC & SteviaFirst | iii |
The restrictions in Clause 15.1 shall not apply to the following: | 30 |
| |
ARTICLE 16 | |
EXECUTION | 30 |
| |
APPENDIX "A" | |
licensed Patents | 31 |
| |
APPENDIX "B" | |
ASSIGNMENT OF MATERIALS | 32 |
Sole License for Stevia Technology – VRIC & SteviaFirst | iv |
Technology license for Stevia-related patents
between
Vineland Research and Innovation Centre
a statutory corporation having its office at
4890 Victoria Avenue North
P.O. Box 4000
Vineland Station, Ontario
L0R 2E0
(“VRIC”)
and
Stevia First Corporation
a company incorporated pursuant to the laws of the State of Nevada
having its registered office at
5225 Carlson Road
Yuba City, California 95993
(“Company”)
introduction
| A. | VRIC was originally known as the Horticulture Research Institute of Ontario, under the Ontario Ministry of Agriculture, Food and Rural Affairs. |
| B. | In 1997, VRIC became under lease an adjunct research facility for the University of Guelph. |
| C. | In 2007 VRIC became an independent body corporate with start-up funding from the Government of Ontario and AAFC with a mandate to self-fund VRIC’s activities. |
| D. | VRIC’s vision is to become an internationally recognized centre of horticulture research and innovation excellence and a significant force in the delivery of horticulture technology. |
| E. | VRIC’s mission is to create industry driven innovation pipelines that create growth in horticulture through value added products and lower costs of production. |
| F. | The four key needs of the horticulture industry are: |
| a. | unique valued-added products that recapture Canadian markets and build export markets; |
| b. | innovative products and systems that meet mounting environmental challenges; |
| c. | production innovations that reduce cost; and |
Sole License for Stevia Technology – VRIC & SteviaFirst | 1 |
| d. | rapid access to new technologies. |
| G. | In order for the horticulture industry to remain competitive, the industry must adapt to changing consumer demands and increased global competition. Adding value to horticultural products is a means to fulfill these demands, create more desirable products, expand market share and increase profits. |
| H. | The subject matter of theLicensed Patents was developed at, and the patents were protected by, Agriculture and Agri-Food Canada (“AAFC”), a department of the Government of Canada. TheseLicensed Patents were developed by Dr. Jim Brandle in his capacity as a research scientist at AAFC. |
| I. | In 2010, AAFC assigned all ownership rights for theLicensed Patents to VRIC, subject to certain terms and conditions, including a right by AAFC to continue to perform research related to theLicensed Patents and to be informed about all improvements or commercially-useful developments concerning theMaterials.AAFC did not retain any rights related to commercialization of theLicensed Patents. |
| J. | VRIC is the owner of theLicensed Patents andMaterial. |
| K. | The Company is seeking to establish a vertically-integrated stevia enterprise with expertise in stevia seed and tissue propagation, plant breeding and cultivation. |
| L. | In order to achieve its goals, the Company is interested in exclusive rights to theLicensed Patents and purchase of theMaterials to further its business activities in the sweetener industry. |
| M. | The Company is also interested in retaining limited consulting services from Dr. Jim Brandle, now the CEO of VRIC. Vineland and the Company are entering into a separatenon-exclusive consulting agreement (“Non-Exclusive Consulting Agreement”), which is to be executed at the same time as this Agreement and extends for a term of one (1) year (and is renewable for an additional year). |
| N. | Dr. Brandle is entering into theNon-Exclusive Consulting Agreementwith the knowledge and consent of the VRIC’s Board of Directors and as a CEO not as an individual. |
NOW THEREFORE in consideration of the premises, the terms and conditions hereinafter contained and other good and valuable consideration, the receipt of which is hereby acknowledged by each party, theParties hereto covenant and agree as follows:
ARTICLE 1
definitions
| 1.1.1 | without limitation, any controversy, conflict, claim, disagreement or difference of opinion arising out of theLicense, (irrespective of whether it is premised on contract, tort or trust / equity, (or other legal basis or principles) including, without limitation, any issues concerning the breach, interpretation, rectification, termination, performance, enforcement or validity of theLicense, or the rights and liabilities of theParties in relation to theLicense; |
Sole License for Stevia Technology – VRIC & SteviaFirst | 2 |
| 1.1.2 | irrespective of the fact that there is no arguable defense under theLicense, or that the facts or law are undisputable and subject to judicial summary proceedings; |
butDispute does not encompass any controversy, conflict, claim, disagreement or difference of opinion or the rights and liabilities of thePartiesunder any collateral or antecedent agreements independent of theLicense.
means the date of the last signature to theLicense as noted in ARTICLE 16 (Execution).
| 1.3 | "Field of Use" means the sweetener industry within the compass of theProducts,Licensed PatentsandLicensed Rights thereunder. |
| 1.4 | "License"means this agreement including any amendments and the attached appendices; and refers to the whole of this agreement, not to any particular section or portion thereof. |
| 1.5 | “Licensed Patents”means (i) the Patents and Applications described in Schedule 1; and (ii) any and all other patent application(s), patents, divisionals, continuations, and continuations in part arising therefrom; and (iii) any and all other Patent Rights obtained in pursuance of or deriving priority from the Patent Rights listed in items (i) and (ii) hereof. A list of Patent Rights as of the Commencement Date is set forth in APPENDIX “A”. |
| 1.6 | "Licensed Rights" means the rights to theLicensed Patents as authorized in theLicense with respect to the creation ofProducts and theSale of theProducts. |
| 1.7 | “Material”means any and all seeds and plant material provided by VRIC. “Material” also means any and all plants, plant parts, cuttings, germplasm, genetic materials, and seeds, derived therefrom. A description of this seed and plant material is provided in APPENDIX “B”. |
| 1.8 | “Non-Exclusive Consulting Agreement”means theNon-Exclusive Consulting Agreement between VRIC and the Company for consulting services rendered by Dr. Jim Brandle, co-executed with thisLicense. |
| 1.9 | “Patent Rights”means any patent applications, patents, author certificates, inventor certificates, utility certificates, utility models and all foreign counterparts of them and includes all divisions, renewals, continuations, continuations-in-part, extensions, reissues, substitutions, provisional applications, continued prosecution applications, requests for continued examinations, re-examinations, confirmations, registrations, revalidations and additions of or to them, as well as any supplementary protection certificate, or like form of protection. |
| 1.10 | “Party”means any one of the signatories to theLicenseand “Parties” means both of them and their respective servants, agents, and employees. |
| 1.11 | “Product”means without limitation any steviol, steviol glycoside extract, or rebaudioside extract that falls within the scope of a valid claim of aLicensed Patent. |
Sole License for Stevia Technology – VRIC & SteviaFirst | 3 |
| 1.12 | "Sale" or "Sell"means |
| 1.12.1 | the selling or offering to sell ofProducts; |
| 1.12.2 | within theTerritory only (without right of export from any national jurisdiction within thatTerritory, including jurisdictions in which thePatents are not registered or applied for); |
| 1.12.3 | the inclusion of aProduct as an ingredient in an item offered for sale by the Company or its sub-licensees. |
| 1.13 | "Sales Price"means the price paid by an arm’s length purchaser for anyProduct sold by the Company or its sub-licensees or the price paid for suchProduct in similar quantities of suchProduct if theProduct is used as an ingredient in an item offered for sale by the Company or its sublicensees. |
| 1.14 | "Taxes"means taxes (including, without limitation, sales taxes, Goods and ServicesTaxes, value added taxes, however described), levies, imposts, deductions, charges, license and registration fees, assessments, withholdings / withholding taxes and duties imposed by any jurisdiction or authority (including stamp and transaction taxes and duties) together with any related interest, penalties, fines and expenses in connection with them. |
| 1.15 | "Term"means the period prescribed in ARTICLE 3 (Term), including any extensions or renewals. |
| 1.16 | "Territory"means worldwide. |
ARTICLE 2
grant & reservations
Subject to the Company fulfilling the provisions of theLicense and any third party antecedent peremptory rights, VRIC grants to the Company a personal, non-transferable, exclusive, fixed term, revocable, royalty-bearing license to create andSell theProducts as an exercise of theLicensed Rights within theTerritory. Nothing herein shall constitute in any manner whatsoever an assignment or similar transfer of either VRIC’s proprietary rights in theLicensed Patents or those rights forming the basis of theLicensed Rights.
| 2.2 | Assignment of Materials |
The Parties acknowledge that the Materials are germplasm, as such have no extant or pending variety or denomination registration and to the best of the Parties’ knowledge, contain no patented gene. This germplasm will be sold to the Company on the terms identified in subparagraph 5.4.2 (Execution Fees).
Notwithstanding any other provision of theLicense, VRIC shall retain from theLicense any and all rights to theLicensed Patentsnecessary for bona fide research and development and other non-commercial activities. VRIC will not retain any rights related to commercialization of the Licensed Patents.
Sole License for Stevia Technology – VRIC & SteviaFirst | 4 |
| 2.4 | Sub-Licensing Conditions |
The Company is permitted to sub-license to parties that are not affiliates of the Company on not less than the same terms and conditions of thisLicense. The terms and conditions of any sub-license granted by the Company shall include but are not limited to the following:
| 2.4.1 | be royalty-bearing and revocable, with the right to sub-sub-license only on terms that enable the same obligations and restrictions as those required of the Company under theLicense; |
| 2.4.2 | prescribe a royalty rate no less than that prescribed in theLicense; |
| 2.4.3 | be only within theTerritory or any portion thereof; |
| 2.4.4 | be only within theField of Use or a subset thereof; |
| 2.4.5 | be subject to the same obligations and restrictions as those required of the Company under theLicense; |
| 2.4.6 | be in a form determined by the Company with the right to review by VRIC prior to execution; |
| 2.4.7 | be copied to VRIC immediately following execution; and |
| 2.4.8 | not be a de facto assignment. |
For greater clarity VRIC shall receive from the sub-licensees not less than the same amount of consideration VRIC would have received from the Company, had the Company conducted theSale rather than the sub-licensees. The Company shall ensure that any monies owing to VRIC from the sub-licensee is paid to VRIC when due, and the Company shall be liable for any such monies irrespective of whether or not the sub-licensee paid the Company.
| 2.5 | No Sub-Licensee Encumbrances |
The Company has no right to encumber any contractual, legal or equitable rights (or other rights recognized at law) that the Company may have against any sub-licensee in favor of any financial institution or any third party whatsoever if such encumbrance will lead to a reduction in royalty revenues payable pursuant to thisAgreement.
Termination of theLicense shall also terminate any subsisting sub-licenses, but any consideration due or owing to VRIC shall be paid promptly thereafter by the Company, and any and all unsatisfied obligations and rights shall subsist until satisfied. If upon termination, sub-licensee is able to meet the same obligations and restrictions as those required of the Company under theLicense, VRIC will not unreasonably withhold the transfer of theLicense from the Company to sub-licensee.
| 2.7 | The Company Shall Obtain Regulatory Permissions |
The Company shall obtain any material registrations, authorizations, permits, certificates or other regulatory permissions which may be required in order for the Company to legally carry out all of its activities under theLicense, at the Company’s sole cost and expense without right of set-off against royalties or other consideration due VRIC.
Sole License for Stevia Technology – VRIC & SteviaFirst | 5 |
ARTICLE 3
term
TheLicense shall remain in force for ten (10) years from theExecution Date, unless terminated pursuant to the provisions of ARTICLE 11 (Termination).
TheLicense shall be renewed for additional terms on the same terms and conditions herein for multiple additional two (2) year terms on the same terms and conditions contained herein until such time that all Licensed Patents have expired, unless:
| 3.2.1 | the Company is in breach of theLicense and does not remedy such breach as permitted under paragraph 11.1 (By VRIC for Cause); or |
| 3.2.2 | the Company provides sixty (60) days notice as per ARTICLE 14 (Notice) prior to the date of expiration, of the Company’s unconditional intention to withdraw from theLicense. |
ARTICLE 4
EXPLOITATION OF THE VARIETY
The Company shall use reasonable commercial efforts toSellProducts created by exercising theLicensed Rights to end-users and sub-licensees. This obligation includes the twin duties of filling demand and creating demand for theProducts created by exercising theLicensed Rights. Nothing in theLicense authorizes the “shelving”, deferral of, or otherwise enfeebled sales efforts or other activities that neither create demand nor fill demand for theProducts created by exercising theLicensed Rights, and any such activities are a material breach of theLicense.
The Company shall abide the quality control terms prescribed in ARTICLE 6 (Records, Quality Control, Audit).
ARTICLE 5
FEES & ROYALTIES
| 5.1 | Reimbursement for Fees |
| 5.1.1 | REIMBURSEMENT FOR patent FEES |
The Company shall reimburse VRIC within thirty (30) days of receipt of invoice, for all patent maintenance fees incurred by VRIC during theTerm of thisAgreement.
Sole License for Stevia Technology – VRIC & SteviaFirst | 6 |
The Company shall pay to VRIC the cumulative consideration prescribed for all Sales of theProducts sold or used by the Company and its sub-licensees or nominees. This consideration shall be a royalty of 0.5% of theSalePrice for allSales ofProducts, exclusive of all applicable government imposed taxes, levies and fees.
| 5.3.1 | MINIMUM ROYALTY WHEN SALES BELOW MINIMUM |
From the third year of thisAgreement, and thereafter during theTerm of thisAgreement, the Company shall pay to VRIC a minimum annual royalty of $10,000, minus any royalties paid.
| 5.4.1 | Upon theExecution Date, the Company shall pay VRIC $15,000 as a signature fee for theLicense |
| 5.4.2 | Upon theExecution Date, the Company shall pay VRIC $10,000 as full consideration for the assignment of theMaterials. |
| 5.4.3 | The Company shall pay VRIC $12,500 on the six-month anniversary date of theExecution Date; and |
| 5.4.4 | The Company shall pay VRIC $12,500 on the one-year anniversary date of theExecution Date. |
| 5.5 | Sub-Licensing Consideration |
The Company shall pay to VRIC fifteen percent (15%) of all consideration paid or rendered by the sub-licensee to the Company as a condition to being granted a sub-license, whether or not such consideration was directly, indirectly or derivatively paid or provided, including without limitation, any equity. Such payment shall be due within thirty (30) days of receipt of such consideration from the sub-licensee and shall be made in the same currency or form as received from the sub-licensee.
The Company shall payTaxes at the applicable prevailing rates required on the Company’s activities under theLicense, including those owing on the payment of any royalties. Nothing in this paragraph entitles the Company to hold back royalties pending resolution of withholding taxes.
The Company shall pay any monies and consideration owing to VRIC as follows:
Royalties and other consideration with respect to sales of theProductssold during the (12) months preceding the 30th day of June of each calendar year, shall be paid by the Company to VRIC by the 31st day of December of that calendar year.
Sole License for Stevia Technology – VRIC & SteviaFirst | 7 |
Cheques for the payment of royalties and other consideration shall be in Canadian funds and made payable to the “VRIC”. Where royalties generated by sales are in US funds, cheques for the payment of royalties shall be in Canadian funds converted from US funds at the conversion rate stated in the Wall Street Journal on the third business day prior to the date payment is made. The cheques shall be sent to: VRIC, attention Finance at the address listed above.
| 5.7.3 | ACCOMPANYING DOCUMENTATION |
Each cheque shall be accompanied by written reports as specified in paragraph 6.1 (Reports & Records).
| 5.8 | Payments to VRIC after Termination |
The Company shall pay to VRIC any consideration due and payable under theLicense or sub-licenses whether incurred prior to termination or after, in accordance with ARTICLE 11 (Termination).
Notwithstanding any other provision of theLicense, any consideration payable to VRIC by the Company under theLicense is unconditional and non-cancellable. Further, the Company shall not have the right of set-off, deduct or counter-claim against any such consideration.
ARTICLE 6
RECORDS, QUALITY CONTROL, AUDIT
The Company shall on or before the 31st day of December of each calendar year during theTerm, submit to VRIC’s contact person identified in paragraph 14.1 (Addresses/Contacts), written reports as to the Company's activities with respect to theLicensed Rights during the twelve (12) months period preceding the 30th day of November. Such reports shall contain:
| 6.1.1 | MARKETING EFFORTS & PRODUCTION |
if requested by VRIC acting reasonably, a detailed description of the steps taken by the Company toSell theProducts making an estimate when precise figures are not available, marketing, sub-licensing and sales;
| 6.1.2 | MARKETING CONDITIONS |
if requested by VRIC acting reasonably, a description of the marketing conditions for theLicensed Rights;
Sole License for Stevia Technology – VRIC & SteviaFirst | 8 |
| 6.1.3 | SUB-LICENSE(S) DETAILS |
a statement including the names and addresses of all sub-licensees to whom theLicensed Patentshas been sub-licensed, a full account of all revenues generated by such sub-licenses, and a calculation of the amount due to VRIC for the consideration stipulated therein.
| 6.2 | Quality Control Obligations |
The Company shall comply in all material respects with all quality requirements for theProducts created exercising theLicensed Rights and theSale of theProducts that are prescribed by any applicable regulatory or statutory authority.
| 6.3 | Quality Control Audits |
VRIC shall have the right, exercised at all reasonable times during regular business hours on five (5) days prior written notice to the Company, and at its own cost, to inspect theProducts created exercising theLicensed Rights at any time within theTerritory to ensure theProducts created exercising theLicensed Rights satisfies all quality control obligations prescribed under paragraph 6.2 (Quality Control Obligations).
| 6.3.1 | The Company shall ensure that this provision is in any sub-license and brought to the attention of the sub-licensee. |
The reporting requirements given in paragraph 6.1 (Reports & Records) and the quality control requirements given in paragraphs 6.2 (Quality Control Obligations) and 6.3 (Quality Control Audits) are material terms of thisLicense.
| 6.5 | Reports & Records Audit Rights |
VRIC shall have the right, exercised at all reasonable times during regular business hours, on five (5) days prior written notice to the Company, and at its own cost, to conduct an audit of the Company’s records concerning theSale of theProducts, and to make copies of all such records. Upon the written request of VRIC, the Company shall permit an independent public accountant, retained by VRIC at its own cost subject to paragraph 6.8 (Discrepancy Percentage), to inspect all relevant records. The audit shall focus on the Company’s payment of royalties or consideration paid to VRIC and the accuracy of any reports previously submitted to VRIC as detailed in paragraph 6.1 (Reports & Records). This right shall survive for twelve (12) months immediately following termination or expiration of theLicense.
The independent public accountant retained by VRIC shall inform VRIC whether or not the Company has complied with its obligations under theLicense to submit reports and to pay royalties and consideration due and payable to VRIC. Subject to the information contained in the foregoing audit reports, the independent public accountant shall not reveal to VRIC any of the Company’s internal documentation or records.
Sole License for Stevia Technology – VRIC & SteviaFirst | 9 |
Any royalty payment or report accepted by VRIC shall not constitute a waiver by or estoppel against VRIC concerning the contractual right to audit the Company, and VRIC shall continue to have the right to audit as prescribed in theLicense. Furthermore, an audit shall not preclude VRIC from conducting any subsequent audit or audits or other matters provided in thisLicense or other matters provided in thisLicense.
| 6.8 | Discrepancy Percentage |
In the event of any discrepancy uncovered by the audit:
| 6.8.1 | the Company shall pay forthwith to VRIC the discrepancy; or |
| 6.8.2 | if the discrepancy is equal to or greater than US$7,500, or 10% of the amount owed to VRIC, whichever is greater, the Company shall pay forthwith to VRIC the discrepancy and the cost of the audit (such audit costs will be commercially reasonable); or |
| 6.8.3 | if the Company submits more royalties than required, these overpayments shall be returned forthwith to the Company. |
ARTICLE 7
DISCLAIMERS
VRIC owns all rights to, related to, connected with or arising out of theLicensed Rights, including but without limiting the generality of the foregoing patent rights and copyright in and the right to produce and publish or cause to be produced and published all information, material and documents, are the sole property of VRIC.
The Company shall have no rights in theLicensed Rights except as expressly granted in thisLicense.
The Company shall not impeach or otherwise attack, directly or indirectly, VRIC’s statutory, regulatory or proprietary rights in theLicensed Rights nor assist any third party to do so.
| 7.4 | Disclaimer of Express / Implied Warranties |
Except as provided in paragraph 8.2 (VRIC Authorized) or otherwise expressly stated in thisLicense or in APPENDIX "A" (Licensed Patents), VRIC makes no warranties, representations or conditions, express or implied, of any nature, and VRIC disclaims all warranties, representations or conditions, for theLicensed Rights regarding:
Sole License for Stevia Technology – VRIC & SteviaFirst | 10 |
| 7.4.3 | fitness for any or a particular purpose; |
| 7.4.4 | commercial utility or practical purpose; |
| 7.4.5 | susceptibility of yielding valuable results or results are free of defects or otherwise harmless; |
| 7.4.6 | latent or other defects; |
| 7.4.7 | infringement or non-infringement ofPatent or other third party rights; |
| 7.4.8 | conformity with the laws of any jurisdictions outside of VRIC; or |
| 7.4.9 | fitness for the Company’s corporate objectives (whether or not expressly or impliedly communicated to VRIC). |
For greater certainty, no information or advice given by VRIC shall create a warranty or representation or condition other than as expressly stated in theLicense. The Company accepts theLicensed Patentsand Materials “as is”, with all faults, and the entire risk as to satisfactory quality, performance, accuracy and effort is with the Company other than as expressly stated in thisLicense.
| 7.5 | Disclaimer of Statutorily Implied Warranties |
No legal or equitable warranties or conditions implied by law or convention under any domestic, foreign or international legal regime, or from a course of dealing or usage of trade, shall apply to theLicense. The Company acknowledges this disclaimer and is estopped from relying on any such representations, warranties or conditions against VRIC.
| 7.6 | No Liability to VRIC from Exercise of Rights |
The Company agrees that it is responsible for the manner in which itSells theProducts created in exercising theLicensed Rights. The Company will have no recourse against VRIC with respect to any consequences of such action, except where allowed in thisLicense.
| 7.7 | Disclosure & Due Diligence |
The Company acknowledges that:
| 7.7.1 | VRIC has made full and frank disclosure of all facts the Company deemed relevant before executing theLicense; |
| 7.7.2 | The Company has conducted a due diligence search of all matters relevant to theLicensed Rights and theLicense; and |
Sole License for Stevia Technology – VRIC & SteviaFirst | 11 |
ARTICLE 8
CORPORATE REPRESENTATIONS & WARRANTIES
| 8.1 | The Company Incorporated & Authorized & Bound |
The Company represents and warrants to VRIC that as of theExecution Date:
it has the legal capacity toSell theProducts created in exercising theLicensed Rights, and the Company has the necessary access to funds, resources, knowledge, facilities and personnel to perform its obligations under theLicense, subject to all applicable laws;
it is authorized and has the corporate power and authority to negotiate, execute, comply with and satisfy its obligations, without qualification, under theLicense;
| 8.1.3 | INCORPORATION JURISDICTION |
it has been duly incorporated and organized under the laws of Nevada, and is validly existing under the laws of Nevada;
it is duly qualified, licensed or registered to carry on business in those jurisdictions included in theTerritoryin which it does business;
it is bound by theLicense, upon execution, and theLicense constitutes a legal, valid and binding obligation on the Company, enforceable against the Company in accordance with the terms of theLicense, except as those terms may be limited by applicable bankruptcy laws and general principles of equity;
to the best of its knowledge, there is no legal proceeding or order pending against or, to the knowledge of the Company, threatened against or affecting the Company or any of its properties or otherwise that could materially adversely affect or restrict the ability of the Company to consummate fully the transactions contemplated by thisLicense, or that in any manner draws into question the validity of thisLicense;
| 8.1.7 | VERACITY OF STATEMENTS |
no representation or warranty by the Company contained in thisLicense and no statement contained in any certificate, schedule or other instrument furnished to VRIC pursuant hereto or in connection with the transactions contemplated hereby, contains any intentional untrue statement of a material fact or intentional omission of a material fact;
Sole License for Stevia Technology – VRIC & SteviaFirst | 12 |
| 8.1.8 | INCONSISTENT AGREEMENTS / OBLIGATIONS |
it has not given any understanding, express or implied, to any third party which would:
| 8.1.8.1 | preclude the Company from fulfilling the its obligations under theLicense or |
| 8.1.8.2 | cause the Company to breach an agreement with a third party. |
it is not subject to any "march in" or third party rights, (contractual or statutory, contingent or vested) which would give that third party any rights to theLicensed Rights not otherwise explicitly described in theLicense; and
| 8.1.10 | NO BREACH OF THIRD PARTY AGREEMENTS |
to the best of its knowledge, its execution of theLicense does not contravene its constituent documents or any law, regulation or official directive or any of its obligations or undertakings by which it or any of its assets are bound or cause a limitation on its powers or the powers of its directors to be exceeded.
VRIC represents and warrants to the Company as of theExecution Date:
| 8.2.1.1 | VRIC has the power and authority to negotiate, execute and comply with theLicense, subject to all applicable laws and the royal prerogative; and |
| 8.2.1.2 | no further action is required by or in respect of any governmental or regulatory authority; |
| 8.2.1.3 | to the best of VRIC’s knowledge, theLicense does not contravene, violate or constitute a breach or default under any requirement of law applicable to VRIC or any contract to which VRIC is bound is or is subject to; and |
| 8.2.1.4 | theLicense is a legal, valid and binding obligation on VRIC and enforceable against VRIC in accordance with its terms; and |
| 8.2.1.5 | VRIC has been duly incorporated and organized under the laws of Ontario, and validly exists under the laws of Ontario. |
Sole License for Stevia Technology – VRIC & SteviaFirst | 13 |
ARTICLE 9
INDEMNITY, INSURANCE, LIABILITY ALLOCATION & CAPS
| 9.1 | The Company’s Indemnification |
| 9.1.1.2 | save harmless, and |
| 9.1.1.3 | defend at its own costs |
VRIC (including its employees, servants, agents, officers and advisors):
| 9.1.1.4 | from and against all claims, demands, losses, penalties, damages, costs, (including reasonable legal fees and disbursements), actions, suits or other proceedings; |
| 9.1.1.5 | brought or prosecuted in any manner which heretofore or hereafter may be made by whomever against VRIC; |
| 9.1.1.6 | however and whenever arising out of, relating to, occasioned by or attributed to, any misrepresentations or breach of warranty made in thisLicense or any failure to perform its obligations under thisLicense by the Company (including in this ARTICLE 9, its employees, servants, agents, advisors or sub-licensees) whether by reason of negligence or otherwise. |
| 9.2 | Indemnity Separate / Continuing |
The foregoing indemnity is a continuing obligation, separate and independent from the other obligations of the Company and survives termination of, expiration of, or the acceptance of repudiation of theLicense. It is not necessary for VRIC to incur expense or make payment before enforcing a right of indemnity conferred hereunder.
The Company shall ensure that both the Company and each of its sub-licensees shall obtain and maintain, throughout theTerm of theLicense or duration of the sub-licenses (as the case may be), commercial general liability insurance of not less than one million dollars (US$1,000,000.00) per incident for any and all claims, actions, liabilities and expenses resulting from theProducts created exercising theLicensed Rights, including but not limited to product liability.
VRIC shall indemnify, save harmless and defend at its own costs the Company (and its employees, servants and agents) for damages to property or death of or injury to any person caused sustained or incurred due to the negligence of VRIC. Notwithstanding the foregoing, VRIC shall not be required to indemnify the Company hereunder to the extent arising out of or which would not have arisen but for:
| 9.4.1 | the negligence, fraud or willful misconduct on the part of the Company, its employees, servants or agents; |
| 9.4.2 | a breach by the Company of its obligations, representations and warranties hereunder; or |
| 9.4.3 | an unauthorized assignment by the Company of theLicense. |
Sole License for Stevia Technology – VRIC & SteviaFirst | 14 |
VRIC’s liability for:
| 9.5.1 | breach of the representations, conditions or warranties contained herein or any of the other provisions of theLicense or any other breach giving rise to liability, including a breach of a condition or fundamental term or fundamental breach or breaches; or |
| 9.5.2 | in any other way arising out of or related to theLicense; or |
| 9.5.3 | for any cause of action whatsoever and regardless of the form of action (including breach of contract, trust, strict liability, tort [including negligence and misrepresentation], or any other legal or equitable theory; |
shall be limited to the Company’s actual direct (immediate and foreseeable at the time of negotiation to bothParties), provable damages in an amount not to exceed in the aggregate a sum equal to or less than the net consideration received by VRIC from the Company under ARTICLE 5 (Fees and Royalties) for the time period commencing from theExecution Date up to and including the date of judicial judgment or arbitrator’s decision.
| 9.6 | Excluded Heads of Damage |
VRIC shall not be liable to the Company, its successors, assigns, or sub-licenses for damages in respect of:
| 9.6.1 | incidental, indirect, special, punitive, exemplary damages; |
| 9.6.2 | any economic loss, consequential damages, relational loss, including but not limited to lost business revenue, lost profits, business interruption, failure to realize expected savings, loss of data, loss of business opportunity suffered by the Company or any claim whatsoever and whenever made against the Company by any other party; |
whether grounded in tort (including negligence), strict liability, contract, trust or otherwise, even if:
| 9.6.3 | VRIC was advised of the possibility of such damages, or |
| 9.6.4 | the damages encompassed by sub-paragraphs 9.6.1 and 9.6.2 were foreseeable by VRIC, or |
| 9.6.5 | such damages resulted from a fundamental breach of theLicense. |
Further, VRIC shall have no duty to warn the Company for matters arising directly or indirectly under theLicense.
| 9.7 | No Actions Against Employees |
The Company acknowledges and is estopped (prevented) from and waives any rights the Company might have to commence and prosecute any action whatsoever, regardless of form or grounds (including without limitation negligence, misrepresentation, fiduciary, deceit) against any of VRIC’s employees, servants, agents or officers, arising out of any claimed breach of theLicense or transactions under theLicense or negotiations leading to theLicense, or in any other way related to theLicense. For greater clarity, the Company’s remedies for any breach of orDispute under theLicense, lies only against VRIC, and only within the aforementioned parameters prescribed by theLicense.
Sole License for Stevia Technology – VRIC & SteviaFirst | 15 |
The indemnified party shall notify the indemnifying party of any claim that falls within the parameters of the respective indemnification obligations as soon as practical. In any case such notice shall be made forthwith upon notice that a claim may be prosecuted or a cause of action exists.
ARTICLE 10
INFRINGEMENT
Subject to ARTICLE 9 (Indemnity, Insurance, Liability Allocations & Caps), VRIC authorizes the Company to pursue any third party infringing theLicensedRights granted to the Company under thePlant Breeders’ Rights Act or theU.S. Plant Variety Protection Act, 1970, or any other applicable legislation. In the event of any threatened or actual suit against the Company in consequence of the exercise right and theLicensegranted herein, the Company shall promptly inform VRIC and theParties will jointly decide on the steps to be taken in the circumstances.
| 10.2 | Infringement Uncovered |
EachPartywill notify the other promptly in writing when any infringement is uncovered or suspected.
The Company shall have the right to enforce thePatents and related rights against any infringement or alleged infringement thereof, and shall at all times keep VRIC informed as to the status thereof. Subject to VRIC’s prior written approval (which will not be unreasonably withheld), the Company may, at its own expense, institute suit against any such infringer or alleged infringer and prosecute such suit in a manner consistent with the terms and conditions hereof. VRIC shall reasonably cooperate in any such litigation at Company’s expense, and Company shall keep VRIC apprised in a timely manner of all litigation activities. In any litigation under this Article, the Company shall not have the right to settle or otherwise compromise VRIC’s position as a licensor or owner of thePatents without VRIC’s prior written consent.
| 10.4 | Distribution of Company’s Recovery |
In the event of a recovery by the Company of compensatory damages (i.e. non-punitive damages net of legal fees and out of pocket costs of the action) under paragraph 5.2 (Royalty Rate) for a royalty-bearingProduct created exercising theLicensed Rights, the Company shall pay to VRIC the applicable royalty rate on infringing sales. Infringing sales shall be determined by, and calculated from, the amount of infringing sales on which the award of compensatory damages is based. With respect to any recovery of punitive damages, the Company shall pay to VRIC an amount equal to 15% of such recovery, net of all solicitor-client costs and expenses related to the proceedings leading to the recovery.
Sole License for Stevia Technology – VRIC & SteviaFirst | 16 |
If the Company elects not to enforce thePatents and related rights, then the Company shall so notify VRIC in writing within six (6) months of receiving notice that an infringement exists, and VRIC may, in its sole judgment and at its own expense, take steps to enforce itsPatents and related rights, settle, and defend such suit in a manner as VRIC deems fits, even if such settlement might compromise viability of theLicense, and recover for its own account any damages, awards, or settlements resulting therefrom.
ThePartiesacknowledge that the mere fact of an infringement in a jurisdiction is insufficient to merit enforcement proceedings, unless such infringement in a material and in a significant way negatively affectsSales, and the evidence of the infringement is compelling, probative, and ethically gathered.
ARTICLE 11
TERMINATION
TheLicense, at the option of VRIC, without prejudice to any other rights in law or equity or any other legal basis or principles held by VRIC (including any right of indemnity), may be terminated forthwith by VRIC without compensation to the Company if:
the Company fails to use reasonable commercial efforts toSell theProducts created exercising theLicensed Rights;
the Company fails to make any payment provided for herein and does not make such payment within sixty (60) days of the due date irrespective of whether or not a reminder or other notification was sent to the Company;
| 11.1.3 | QUALITY CONTROL & AUDIT |
the Company refuses, neglects or fails to meet material quality standards or allow access for quality audit purposes contrary to ARTICLE 6 (Records, Quality Control, Audit); or provide or allow the audit of the reports and records as required under Article 6 (Records, Quality Control, Audit) and does not remedy the breach within sixty (60) days after being required in writing to do so by VRIC;
the Company ceases to actively carry on business;
Sole License for Stevia Technology – VRIC & SteviaFirst | 17 |
| 11.1.5 | CRIMINAL CONVICTION |
the Company was convicted of a material criminal or regulatory offence, the nature of which materially directly or indirectly affects the ability of the Company to conduct itself under theLicense, or toSelltheProducts created exercising theLicensed Rights in an effective and timely manner, or otherwise materially prejudicesSales;
the Company commits or permits a material breach of any of the other terms and conditions herein contained and does not remedy such breach within sixty (60) days after being required in writing to do so by VRIC;
the Company expressly or implicitly repudiates theLicense by refusing or threatening to refuse to comply with any of the provisions of theLicense;
| 11.1.8 | AGGREGATE ROYALTY QUANTUM |
the Company has not paid in the aggregate any royalties in excess of the minimum annual payment prescribed under paragraph 5.3 (Minimum Royalty) for five (5) consecutive years; and); or
The Company becomes bankrupt or insolvent or otherwise
| 11.1.9.1 | has a receiving or winding up order made or sought against it |
| 11.1.9.2 | has a meeting proposed or convened, seeking or actually passing a resolution to appoint a trustee or official manager |
| 11.1.9.3 | as a receiver, receiver-manager, liquidator, trustee in bankruptcy, custodian or any other officer with similar powers appointed for the Company or such an order is sought; |
| 11.1.9.4 | has any or all of its assets seized or otherwise attached for the benefit of creditors; |
| 11.1.9.5 | proposes or convenes a meeting to seek or passes a resolution for winding up; |
| 11.1.9.6 | takes the benefit of any statute, at the time in force, relating to bankrupt or insolvent debtors for the orderly payment of debts; |
| 11.1.9.7 | makes a general assignment for the benefit of creditors; |
| 11.1.9.8 | submits a proposal or arrangement under any debtor/creditor legislation; |
| 11.1.9.9 | is the subject of a petition or files an assignment under Bankruptcy and Insolvency Act or any successor legislation; or |
Sole License for Stevia Technology – VRIC & SteviaFirst | 18 |
| 11.1.9.10 | does or attempts anything analogous to the aforementioned events or having a substantially similar effect to any of the aforementioned events under the laws of any jurisdiction. |
| 11.2 | Automatic Termination |
TheLicenseand all rights granted to the Company pursuant to theLicense shall immediately terminate and revert to VRIC by operation of contract, without prejudice to any other rights in law or equity or any other legal basis or principles held by VRIC (including any right of indemnity) and without compensation to the Company, effective the business day prior to the applicable triggering event, namely if:
the Company assigns theLicensewithout the prior written consent of VRIC, contrary to the provisions of paragraphs 13.2 and 13.3 (Assignment).
| 11.3 | Termination Not A Penalty |
The Company acknowledges and is estopped (prevented) from alleging otherwise, that the termination provisions in paragraph 11.1 (By VRIC for Cause) do not constitute a penalty, and are otherwise fair, just and proportional given the nature of theParties, their respective mandates and corporate objectives, the allocation of risks under theLicense, the goals of theParties, nature of theProducts created in exercising theLicensed Rights, and the consequences to VRIC if the Company commits the aforementioned breaches.
Termination shall be implemented by a notice effective as of the date stated therein, but termination shall be subject to paragraph 11.6 (The Company’s Duties on Termination) and be without prejudice:
| 11.4.1 | to the right of VRIC to sue for and recover any royalties or other sums due VRIC; and |
| 11.4.2 | to the remedy of eitherPartyin respect of any previous breach of theLicense. |
| 11.5 | Effect on Sub-Licensees |
All sub-licenses shall terminate with theLicense. If upon termination, sub-licensee is able to meet the same obligations and restrictions as those required of the Company under theLicense, VRIC will not unreasonably withhold the transfer of theLicense from the Company to sub-licensee.
| 11.6 | The Company’s Duties on Termination |
Upon termination, expiration or surrender of theLicense, the Company shall at its own cost:
| 11.6.1 | deliver a detailed statement to VRIC of the inventory of theProductscreated exercising theLicensed Rights then existing, but not sold by the Company, as of the date of termination, expiration, or surrender; |
Sole License for Stevia Technology – VRIC & SteviaFirst | 19 |
| 11.6.2 | pay all costs due under theLicenseeither by the Company on its behalf or a sub-licensee, up to and including the termination, expiration, or surrender date, within thirty (30) days of the termination, expiration, or surrender; |
| 11.6.3 | pay all costs due under theLicense, subsequent to the termination, expiration, or surrender, for anyProductssold within thirty (30) days of the termination, expiration, or surrender, within seven (7) days of the liability being incurred; and |
| 11.6.4 | if terminated pursuant to Section 11.1 or 11.2: |
| 11.6.1.1 | grant back to VRIC any research data arising from theProductscreated exercising theLicensed Rights or otherwise under theLicense; |
| 11.6.1.2 | provide VRIC the first right of refusal to purchase from the Company anyProducts created exercising theLicensed Rights, in inventory at fair market value; |
| 11.6.1.3 | dispose of any remainingProductinventory created exercising theLicensed Rights as specified by VRIC; and |
| 11.6.1.4 | assign to VRIC (or its nominee) any other know-how and data which the Company has or alleges to have created exercising theLicensed Rights or derived in theSellingof theProductswithin theField of Use. The Company shall also execute such further documentation as VRIC may reasonably request in order to confirm such assignment; and |
| 11.6.1.1 | is not terminated earlier pursuant to Section 11.1 or 11.2, |
| 11.6.1.2 | the Term of the Agreement expires, |
| 11.6.1.3 | the Agreement is surrendered, or |
| 11.6.1.4 | the Agreement is terminated for other reasons, |
then the Company shall comply with all applicable post-termination, expiration or surrender procedures under theLicense Agreement. Nothing in theLicense Agreement derogates, assigns, or otherwise fetters the Company’s own foreground intellectual property created during the currency of theLicense Agreement and outside the compass of theLicensed Patents.
| 11.7 | Surviving Obligations |
All obligations of thePartieswhich expressly or by their nature survive termination, expiration, or surrender of theLicenseshall continue in full force and effect subsequent to and notwithstanding such termination or expiration, until they are satisfied or by their nature expire, including but not limited to indemnification, records, quality control, audit, and royalties.
Sole License for Stevia Technology – VRIC & SteviaFirst | 20 |
ARTICLE 12
INTENT & INTERPRETATION
| 12.1 | Use of Alternate Dispute Resolution |
If aDisputearises between theParties, then within six (6) months from when the allegedly aggrievedParty knows or should know of theDispute, the contact individuals in ARTICLE 14 (Notice) of theLicenseshall,
| 12.1.1 | contact their counterpart, and attempt bona fide efforts to diligently resolve theDisputethrough amicable negotiations; |
| 12.1.2 | provide full, frank and timely disclosure of all relevant facts, information and documents to facilitate those negotiations; |
| 12.1.3 | resolve theDisputewithin thirty (30) days, failing which: |
TheAgreement shall be terminated, subject to the terms of paragraphs 11.4, 11.5, and 11.6.
TheLicenseconstitutes the entire and exclusive agreement between theParties pertaining to theSaleof theProducts created in exercising theLicensed Rights, and supersedes all prior agreements, conditions, obligations, understandings, and negotiations both written and oral. TheLicense sets forth all obligations, undertakings, conditions, representations and warranties forming part of, or in any way affecting or relating to theSaleof theProducts created exercising theLicensed Rights. TheParties acknowledge that with respect to theSaleof theProducts created in exercising theLicensed Rights, there are no agreements, obligations, undertakings, representations or warranties whether collateral, oral or written, between the Company and VRIC other than those expressly set out in theLicenseand the Non-Exclusive Consulting Agreement.
TheLicenseis not intended to confer upon any person other than theParties, any rights or remedies hereunder.
| 12.4 | No Pre-Contractual Inducing Representations |
TheLicensesupersedes and revokes all negotiations, arrangements, letters of intent, offers, proposals, brochures, term sheets, representations, memoranda of understandings and information conveyed, whether oral or in writing or electronically, between theParties, or any other person purporting to represent the Company or VRIC. TheParties agree that:
| 12.4.1 | neither has been induced to enter into theLicense by any representations whatsoever not set expressly forth in theLicense; |
| 12.4.2 | neither has relied on any such representations; |
| 12.4.3 | no such representations shall be used in the interpretation or construction of theLicense; and |
Sole License for Stevia Technology – VRIC & SteviaFirst | 21 |
| 12.4.4 | no claims (including, without limitation, loss of profits, indirect, incidental, consequential damages and economic loss) arising directly or indirectly, from any such representation, negligent or otherwise, shall accrue in law or equity or any other legal basis or principles, or be pursued by the Company, and VRIC shall have no liability for any such claims. |
The Company agrees that it has conducted its own due diligence examinations in order to satisfy itself of the full, true and plain disclosure of all facts pertinent to theLicensed Patents and all representations made by VRIC.
| 12.6 | Independent Legal Advice |
It is acknowledged by thePartiesthat each has had legal advice to the full extent deemed necessary by eachParty. Furthermore, theParties acknowledge that neither acted under any duress in negotiating, drafting and executing theLicense.
| 12.7 | No Adverse Presumption in Case of Ambiguity |
There shall be no presumption that any ambiguity in theLicense be resolved in favor of either of theParties. For greater certainty, thecontra proferentum rule (or analogous concept under any other legal basis or principles) shall not be applied in any interpretation of theLicense.
If any part of theLicenseis declared or held any or all of invalid, void, or contrary to public policy for any other reason, then:
if the invalid provision is not material or fundamental to theLicense, the invalid provision shall not affect the validity of the remainder which remainder shall continue in full force and effect and be construed as if theLicensehad been executed without the invalid provision; and
| 12.8.2 | MATERIAL OR FUNDAMENTAL |
if the invalid provision is material or fundamental to theLicense then theLicenseshall terminate effective the 31st day from either the final judicial judgment or arbitral tribunal award.
| 12.9 | Successors and Assigns |
TheLicensewill be for the benefit of and be binding upon the heirs, executors, administrators, permitted successors, and permitted assigns of the Company and other legal representatives, as the case may be, of each of theParties. Every reference in theLicense to anyPartyincludes the heirs, executors, permitted administrators, permitted successors, and permitted assigns, and other permitted legal representatives of theParty.
Sole License for Stevia Technology – VRIC & SteviaFirst | 22 |
Reference to aPartywill be read as if all required changes in the singular and plural and all grammatical changes rendered necessary by gender had been made.
ThePartiesexpressly disclaim any intention to create a partnership, joint venture or joint enterprise. ThePartiesacknowledge and agree that:
| 12.11.1 | nothing contained in theLicensenor any acts of anyPartyshall constitute or be deemed to constitute thePartiesas partners, joint venturers or principal and agent in any way or for any purpose; |
| 12.11.2 | noPartyhas the authority to act for, or to assume any obligation or responsibility on behalf of any otherParty; and |
| 12.11.3 | the relationship between theParties is that of licensor and licensee. |
ThePartiesshall comply, in all material respects, with all applicable laws, as those laws may be amended, revised, consolidated, substituted from time to time, even if such amendment, revision, consolidation, substitution derogates prospectively or retroactivity from theParties’ vested or accrued rights, obligations and liabilities under theLicense.
| 12.13 | No Implied Obligations |
No implied terms or obligations of any kind, by or on behalf of either of theParties, shall arise from anything in theLicense. The express covenants and agreements herein contained and made by theParties are the only covenants and agreements upon which any rights against either of theParties may be founded.
| 12.14 | Forum Conveniens & Applicable Laws |
Subject to Article 12.1, anyDispute shall be governed firstly by applicable Canadian Federal laws, and secondly by the laws of the Province of Ontario (excluding any conflict of laws, venue or forum non conveniens criteria, or other rules or principles that might refer such construction to laws of another jurisdiction). ThePartiesexpressly exclude from theLicense:
| 12.14.1 | application of theUnited Nations Convention on Contracts for the InternationalSaleof Goods; |
| 12.14.2 | TheFederal InternationalSalesof Goods Act (1991, c.13) and theInternationalSalesof Goods Act for the Province of Ontario, as applicable; and |
| 12.14.3 | any conflict of laws, rules or principles which might refer Disputes to the laws of another jurisdiction. |
Sole License for Stevia Technology – VRIC & SteviaFirst | 23 |
TheLicenseshall be treated in all respect as an Ontario VRIC contract. ThePartiesirrevocably and unconditionally attorn to and submit to the exclusive jurisdiction of the courts of Ontario VRIC and all courts competent to hear appeals therefrom with respect to anyDispute now or hereinafter arising under theLicense. ThePartieswaive any right each may have as to object to an action being brought in those courts including, without limitation, by claiming that the action has been brought in an inconvenient forum or that those courts do not have jurisdiction.
| 12.16 | USA Jury Trial Addendum |
The Company waives any right to a trial by jury of any claim, demand action or caution of action:
| 12.16.1 | arising under theLicense; or |
| 12.16.2 | in any way connect with or related or incidental to the dealings of thePartiesin respect of theLicenseor any other agreements or the transactions related hereto or thereto in each case whether now existing or hereafter; |
| 12.16.3 | whether in contract, tort, equity or otherwise. |
The Company agrees and consents that any such claim, demand, action or cause of action shall be decided by a court without a jury. VRIC may file an original counterpart of theLicense with any court, as written evidence of the consent of theParties, to the waiver of their right to a trial by jury.
| 12.17 | Waiver of Counterclaims |
The Company waives any and all of its rights to interpose any claims, deductions, setoffs or counterclaims of any nature in anyDisputewith respect to theLicense.
| 12.18 | Due Diligence Audits |
If, in a subsequent transaction, a thirdParty requires to review thisLicenseas part of a due diligence chain of title search, the Company hereby authorizes the release of thisLicensesubject to deleting any financial or proprietary or other confidential information contained herein.
ThePartiesacknowledge the truth and accuracy of the recitals and acknowledge that the recitals may be used by a court, mediator or arbitrator to help resolve anyDispute.
Subject to making all payments required under theLicense, neitherPartyshall be in breach of any of its obligations under theLicense where the failure to perform or delay in performing any obligation is due, wholly or in part, directly or indirectly to the occurrence of a force majeure event including, without limitation:
| 12.20.1.1 | war, whether declared or not, civil war, revolution, acts of piracy / terrorism, acts of sabotage; |
Sole License for Stevia Technology – VRIC & SteviaFirst | 24 |
| 12.20.1.2 | natural disasters such as violent or destructive storms, cyclones, earthquakes, tidal waves floods, destruction by lightning; |
| 12.20.1.3 | explosions, fires, destruction of machines, factories, and any kind of installation; |
| 12.20.1.4 | boycotts, strikes and lock-outs of all kinds, go-slows, occupation of factories and premises, and work stoppages which occur in the enterprise of thePartyseeking relief; and |
| 12.20.1.5 | acts of governmental bodies, agencies, boards, whether lawful or unlawful. |
But does not include:
| 12.20.1.6 | the lack of regulatory or other approvals, licenses, permits and authorizations necessary for the performance of theLicensewhich are issued by a public authority of any kind whatsoever for which the Company did not apply for or diligently prosecute; |
| 12.20.1.7 | the inability of the affectedParty to obtain financing or any other financial inability on the part of eitherPartyto meet its obligations under theLicense; |
| 12.20.1.8 | force majeure events that the affectedParty knew or should have reasonably known at the time of negotiating theLicensewere probable or avoidable or the effects of which could be minimized, and the affectedPartytook no steps to deal with such force majeure events, including without limitation obtaining the appropriate insurance, using updated machinery; and |
| 12.20.1.9 | the portion of the breach or delay due to the failure of the affectedPartyto take all necessary reasonable steps to minimize, overcome or control the effects of the force majeure event. |
ThePartyaffected by a force majeure event as contemplated in sub-paragraph 12.20.1 (Force majeure - Events) shall:
| 12.20.2.1 | give notice to the otherPartyof such force majeure and its effects on the affectedParty’s ability to perform as soon as practicable after the force majeure and its effects upon the affectedParty’s ability to perform become known to thatParty; and |
| 12.20.2.2 | take all reasonable efforts to correct, compensate or minimize the effect of the force majeure event. |
| 12.20.3 | COMMENCEMENT OF RELIEF |
The affectedPartyshall:
| 12.20.3.1 | be excused of its obligations under theLicense to the extent necessitated by the force majeure event from the time of the force majeure event or if notice was not given as soon as practical, from the receipt of such notice. Failure to give notice makes the failingPartyliable in damages for losses suffered by the otherParty which otherwise could have been avoided; and |
Sole License for Stevia Technology – VRIC & SteviaFirst | 25 |
| 12.20.3.2 | complete or continue performance of its obligations and duties under theLicenseas soon as practical after the cessation, removal, or overcoming of the force majeure event. |
| 12.20.4 | TERMINATION OF AGREEMENT |
If the force majeure event continues in excess of sixty (60) consecutive days or in the aggregate sixty (60) days over any consecutive 200 days, then at any time thereafter eitherParty shall have the option to renegotiate theLicensewith the Company. If theParties are unable to agree to the terms of the proposed amendedLicense within sixty (60) days from the notice to negotiate, then theLicense shall terminate on the 61st day.
| 12.20.5 | POSTPONEMENT OF OBLIGATIONS |
Any obligations of aPartyunder theLicense shall be postponed automatically to the extent and for the period that the affectedParty is prevented from meeting those obligations by reason of any cause beyond its reasonable control (other than lack of funds and applicable regulatory approval). The affectedParty shall immediately notify the otherPartyof the commencement, nature of such cause and probable consequence. The affectedPartyshall also use its reasonable diligent efforts to render performance in a timely manner, utilizing all resources reasonably required in the circumstances.
No condoning, excusing, or overlooking by either of theParties of any default by the otherParty, at any time or times, in performing or observing any of theParties respective covenants, will operate as a waiver renunciation, surrender, of or otherwise affect the rights of thePartiesin respect of any continuing or subsequent default. No waiver of these rights will be inferred from anything done or omitted by theParties, except by an express waiver in writing.
| 12.22 | No Estoppel Due to Third Party Practices |
No custom, practice or usage regarding other licenses between VRIC and other parties shall preclude at any time the strict enforcement of theLicenseby VRIC or the Company.
| 12.23 | Contract Always Speaks |
Where a matter or thing is expressed in the present tense, it shall be applied to the circumstances as they arise, so that effect may be given to theLicenseaccording to its true spirit, intent and meaning.
| 12.24 | Time is of the Essence |
Time shall be of the essence in theLicense with respect to the financial andSaleobligations of the Company.
Sole License for Stevia Technology – VRIC & SteviaFirst | 26 |
| 12.25.1 | All headings in theLicensehave been inserted as a matter of convenience and for reference only, and in no way define, limit, enlarge, modify the scope or meaning of theLicenseor any of its provisions. |
| 12.25.2 | Nevertheless an arbitrator or judge may use any, or all, of the table of contents, recitals, and headings when reviewing the covenants, statements, representations and warranties and conditions subsequent to better understand the commercial and legal intent of theLicense’s provisions. |
Any reference in theLicenseto an Article, paragraph, sub-paragraph, will mean an Article, paragraph or sub-paragraph of theLicense, unless otherwise expressly provided.
| 12.27 | Precedence Over Appendices |
If there is a conflict or ambiguity between theLicense proper and any appendix thereto, the interpretation consistent withLicense proper (taking into consideration the statements in the recitals and headings) shall prevail and apply, notwithstanding any wording to the contrary in the applicable appendix.
Subject to paragraph 12.27 (Precedence Over Appendices) the document attached hereto as APPENDIX "A" and APPENDIX “B” form an integral part of thisLicenseas fully as if they were set forth herein in extenso, and consist of:
Appendix "A" – Licensed Patents
Appendix “B” – Assignment of Materials
ARTICLE 13
LEGAL RIGHTS
No modification or waiver of any provision of theLicense will be inferred from anything done or omitted by either of theParties, except by an express amendment in writing, duly executed by theParties in advance.
TheLicenseis personal to the Company.
| 13.3 | Mode of Assignment / Approval Conditions |
Without derogating from paragraph 13.2 (Assignment), the Company shall not assign (or transfer, sell, encumber, pledge, grant a security interest or otherwise deal) or permit any such assignment, in whole or in part, of theLicense or any of its interest, rights or obligations hereunder, to any non-affiliate without the written consent of VRIC, which consent subject to sub-paragraph 13.3.1 will not be unreasonably withheld.
Sole License for Stevia Technology – VRIC & SteviaFirst | 27 |
| 13.3.1 | Any consent from VRIC shall be contingent and effective only upon receipt by VRIC of payment of any outstanding amounts payable pursuant to thisLicense. |
| 13.3.2 | Consent to any assignment will not be construed as consent to any other assignment. |
| 13.3.3 | No consent from VRIC will be required for the Company to transfer any equity interest in the Company, whether by merger, sale or otherwise. |
| 13.4 | No Consent – Material Breach |
Failure of the Company to obtain the prior written consent of VRIC to any assignment shall be deemed to be a material breach of theLicense.
The Company has the right to subcontract any portion, but not all, of theLicense, subject to the following:
| 13.5.1 | The Company shall notify VRIC in writing of any significant subcontracts or subcontractors who may have an interest in the technology or a collaboration with VRIC; |
| 13.5.2 | the subcontract cannot be a de facto assignment; and |
| 13.5.3 | no rights, obligations, power or control vested in the Company shall be contingently or otherwise transferred to any third party. |
| 13.6 | No Third Party Rights |
Nothing expressed or implied in theLicense is intended to, or shall be construed to confer on or give to, any person other than theParties, any rights or remedies under or by reason of theLicense.
All rights, powers and remedies provided by theLicense are cumulative with, and not exclusive of, the rights, powers or remedies provided by law independently of theLicense.
ThePartieswill at all times hereafter, upon every reasonable request of the other, make, do, and execute or cause to be procured, made, done, and executed, all such further acts, deeds and assurances for the carrying out of the terms, covenants and agreements of theLicense, according to the true intent and meaning of theLicense. These obligations shall continue post termination or expiry until all pre and post termination obligations are satisfied.
Sole License for Stevia Technology – VRIC & SteviaFirst | 28 |
ARTICLE 14
NOTICE
Wherever in thisLicenseit is required or permitted that notice or demand be given, or served by eitherPartyto or on the otherParty, such notice or demand will be in writing and will be validly given or sufficiently communicated if hand delivered or forwarded by electronic transmission, registered mail, priority post mail, telegram, or facsimile or sent by overnight delivery by a nationally recognized courier as follows:
The addresses for delivery are:
To VRIC: | Vineland Research and Innovations Centre 4890 Victoria Ave N Box 4000 Vineland Station, Ontario, Canada L0R 2E0 905.562.0320 lana.culley@vinelandresearch.com |
| |
To the Company: | Stevia First Corporation 5225 Carlson Rd., Yuba City, California, 95993 530.231.7800 (phone) 866.293.0655 (fax) brooke@stevia-first.com |
Notice will be deemed to have been delivered:
| 14.2.1 | if delivered by hand, upon receipt; |
| 14.2.2 | if sent by electronic transmission, forty-eight (48) hours after the time of confirmed transmission, excluding from the calculation weekends and public holidays; |
| 14.2.3 | if sent by registered mail, four (4) days after the mailing thereof, provided that if there is a postal strike or other disruption, such notice will be delivered by hand or electronic transmission. |
ThePartiesmay change their respective addresses for delivery by delivering the notice of change of address to the above noted address, in which case the change will take effect 30 days from that delivery.
Sole License for Stevia Technology – VRIC & SteviaFirst | 29 |
ARTICLE 15
PUBLIC STATEMENTS
Except as provided in Clause 15.2, neither Party shall, without the prior written consent of the other Party:
| 15.1.1 | use in advertising, publicly or otherwise, any trade-name, personal name, trade mark, trade device, service mark, symbol, or any abbreviation, contraction or simulation thereof, owned by the other Party or its Affiliate; or |
| 15.1.2 | represent, either directly or indirectly, that any product or service of the other Party or its Affiliate is a product or service of the representing Party or its Affiliate or that it is made in accordance with or utilizes the information or documents of the other Party or its Affiliate. |
The restrictions in Clause 15.1 shall not apply to the following:
| 15.2.1 | a press release, in a form agreed to in writing by both Parties, publicly announcing this Agreement; or |
| 15.2.2 | use as required by any applicable law or governmental regulation, including, for the avoidance of doubt, compliance with all applicable United States federal and state securities laws, including the United States Securities and Exchange Commission Rules and requirements. |
ARTICLE 16
EXECUTION
IN WITNESS WHEREOF thisLicense has been executed by duly authorized representatives of theParties.
Executed in duplicate, and effective this 28th day of August, 2012.
Stevia First Corporation | | VINELAND RESEARCH AND INNOVATION CENTRE INC. |
| | | | |
Signed: | /s/ Robert Brooke | | Signed: | /s/ J. Brandle |
| | | | |
Printed: | Robert Brooke | | Printed: | J. Brandle |
| | | | |
Title: | President | | Title: | President |
Sole License for Stevia Technology – VRIC & SteviaFirst | 30 |
APPENDIX "A"
licensed Patents
PATENT/APP. NO. | | DESCRIPTION | | COUNTRY/REGION | | FILING DATE |
60/784,168 | | “Compositions and methods for producing steviol and steviol glycosides” | | United States | | March 21, 2006 |
7,927,851 | | “Compositions having ent-kaurenoic acid 13-hydroxylase activity and methods for producing same” | | United States | | March 19, 2007 |
EP1897951B1 | | “Composition and methods for producing steviol and steviol glycosides” | | Europe | | March 20, 2007 |
2,580,429 | | “Compositions and methods for producing steviol and steviol glycosides” | | Canada | | March 21, 2007 |
Sole License for Stevia Technology – VRIC & SteviaFirst | 31 |
APPENDIX "B"
ASSIGNMENT OF MATERIALS
MATERIAL NAME | | DESCRIPTION OF KEY CHARACTERISTICS | | COUNTRY OF ORIGIN |
Stevia seeds | | Seeds derived from publicly available germplasm that were developed as a highly diverse genetic pool from which a breeding program for Stevia could be initiated. | | Seed was originally purchased by Jim Brandle while at AAFC and this population was derived from it. Seed originally came with no restrictions on use. |
Sole License for Stevia Technology – VRIC & SteviaFirst | 32 |